MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jns.2024.122867

Медицинская библиотека · Journal of the neurological sciences · 2024

Clinical characteristics of SARS-CoV-2-associated encephalopathy in children: Nationwide epidemiological study.

Kasai Mariko, Sakuma Hiroshi, Abe Yuichi, Kuki Ichiro, Maegaki Yoshihiro, Murayama Kei, Murofushi Yuka, Nagase Hiroaki, Nishiyama Masahiro, Okumura Akihisa, Sakai Yasunari, Tada Hiroko, Mizuguchi Masashi, Takanashi Jun-Ichi, Japanese Pediatric Neuro-COVID-19 Study Group

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sometimes triggers acute encephalopathy as a serious neurological complication in children. We previously reported the clinico-radiological findings of SARS-CoV-2-associated encephalopathy. The advent of the SARS-CoV-2 omicron variant led to a marked increase in pediatric patients with coronavirus disease 2019 (COVID-19); however, epidemiological changes with acute encephalopathy according to the emergence of SARS-CoV-2 have not yet been documented. Therefore, the present study investigated epidemiological differences in SARS-CoV-2-associated encephalopathy during the BA.1/BA.2 and BA.5 predominant periods and also between SARS-CoV-2-associated and non-SARS-CoV-2-associated encephalopathy.

METHODS

We conducted a nationwide survey of SARS-CoV-2-associated encephalopathy in Japanese children between June and November 2022. We compared the present results during the BA.5 predominant period and previous findings during the BA.1/BA.2 predominant period. We also compared the clinico-radiological syndromes of encephalopathy between SARS-CoV-2-associated and non-SARS-CoV-2-associated encephalopathy.

RESULTS

Although many patients with SARS-CoV-2-associated encephalopathy in the BA.5 predominant period had seizures as their initial symptoms, no significant differences were observed in the clinical features. Patients with SARS-CoV-2-associated encephalopathy had worse outcomes than those with non-SARS-CoV-2-associated encephalopathy (p-value = 0.003). Among 103 patients with SARS-CoV-2-associated encephalopathy, 14 (13.6%) had severe types of acute encephalopathy, namely, encephalopathy with acute fulminant cerebral edema (AFCE) and hemorrhagic shock and encephalopathy syndrome (HSES). Also, 28 (27.2%) patients with SARS-CoV-2-associated encephalopathy had poor outcome: severe neurological sequelae or death. Ninety-five patients (92.2%) were not vaccinated against SARS-CoV-2.

CONCLUSIONS

In SARS-CoV-2-associated encephalopathy, high percentages of AFCE and HSES can result in poor outcomes.

Для цитирования: Kasai Mariko, Sakuma Hiroshi, Abe Yuichi, Kuki Ichiro, Maegaki Yoshihiro, Murayama Kei, Murofushi Yuka, Nagase Hiroaki, Nishiyama Masahiro, Okumura Akihisa, Sakai Yasunari, Tada Hiroko, Mizuguchi Masashi, Takanashi Jun-Ichi, Japanese Pediatric Neuro-COVID-19 Study Group. Clinical characteristics of SARS-CoV-2-associated encephalopathy in children: Nationwide epidemiological study.. Journal of the neurological sciences. 2024. DOI: 10.1016/j.jns.2024.122867.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.